Related Experiment Videos
Induction of partial synchronization of leukemia cells by continuous infusion of low-dose methotrexate followed by
Journal of the National Cancer Institute
|October 4, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.
Cellular & molecular immunology·2020
Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.
Journal of controlled release : official journal of the Controlled Release Society·2018
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia.
The pharmacogenomics journal·2016
Epirubicin in Childhood Acute Lymphoblastic and Myeloid Leukemia in Relapse.
Leukemia & lymphoma·2016
Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorship.
Journal of the National Cancer Institute·2026
Employment after curative breast cancer treatment: the breast cancer and the workforce cohort study.
Journal of the National Cancer Institute·2026
Modeling the survival impact of the Inflation Reduction Act out-of-pocket cap in multiple myeloma.
Journal of the National Cancer Institute·2026
A clinical model incorporating early lymphocyte dynamics in HER2-positive breast cancer.
Journal of the National Cancer Institute·2026
Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop report.
Journal of the National Cancer Institute·2026
Comparative Cardiovascular Outcomes in Acalabrutinib vs. Zanubrutinib in B-Cell Malignancies: A TriNetX Data Study.
Current oncology (Toronto, Ont.)·2026